159 related articles for article (PubMed ID: 7924739)
1. Studies on peroxisomes of colonic mucosa in Crohn's disease.
Aimone-Gastin I; Cable S; Keller JM; Bigard MA; Champigneulle B; Gaucher P; Gueant JL; Dauça M
Dig Dis Sci; 1994 Oct; 39(10):2177-85. PubMed ID: 7924739
[TBL] [Abstract][Full Text] [Related]
2. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
3. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.
Minami T; Tojo H; Shinomura Y; Matsuzawa Y; Okamoto M
Gut; 1994 Nov; 35(11):1593-8. PubMed ID: 7828979
[TBL] [Abstract][Full Text] [Related]
4. Does active Crohn's disease have decreased intestinal antioxidant capacity?
Pinto MA; Lopes MS; Bastos ST; Reigada CL; Dantas RF; Neto JC; Luna AS; Madi K; Nunes T; Zaltman C
J Crohns Colitis; 2013 Oct; 7(9):e358-66. PubMed ID: 23523266
[TBL] [Abstract][Full Text] [Related]
5. Elevated group II phospholipase A2 mass concentration in serum and colonic mucosa in Crohn's disease.
Haapamäki MM; Grönroos JM; Nurmi H; Söderlund K; Peuravuori H; Alanen K; Nevalainen TJ
Clin Chem Lab Med; 1998 Oct; 36(10):751-5. PubMed ID: 9853800
[TBL] [Abstract][Full Text] [Related]
6. Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients.
Sobhani I; Hochlaf S; Denizot Y; Vissuzaine C; Rene E; Benveniste J; Lewin MM; Mignon M
Gut; 1992 Sep; 33(9):1220-5. PubMed ID: 1427375
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of group II phospholipase A2 in colonic mucosa of patients with inflammatory bowel disease.
Minami T; Shinomura Y; Miyagawa J; Tojo H; Okamoto M; Matsuzawa Y
Am J Gastroenterol; 1997 Feb; 92(2):289-92. PubMed ID: 9040208
[TBL] [Abstract][Full Text] [Related]
8. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
9. Ileal and colonic fatty acid profiles in patients with active Crohn's disease.
Bühner S; Nagel E; Körber J; Vogelsang H; Linn T; Pichlmayr R
Gut; 1994 Oct; 35(10):1424-8. PubMed ID: 7959199
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
11. Lower expression of endogenous intestinal alkaline phosphatase may predict worse prognosis in patients with Crohn's disease.
Park SY; Kim JY; Lee SM; Chung JO; Seo JH; Kim S; Kim DH; Park CH; Ju JK; Joo YE; Lee JH; Kim HS; Choi SK; Rew JS
BMC Gastroenterol; 2018 Dec; 18(1):188. PubMed ID: 30558547
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities in the apparently normal bowel mucosa in Crohn's disease.
Goodman MJ; Skinner JM; Truelove SC
Lancet; 1976 Feb; 1(7954):275-8. PubMed ID: 55588
[TBL] [Abstract][Full Text] [Related]
13. Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease.
Thompson JS; Burnett DA; Markin RS; Vaughan WP
Am J Gastroenterol; 1988 Jul; 83(7):756-60. PubMed ID: 3132852
[TBL] [Abstract][Full Text] [Related]
14. Real-time PCR quantification analysis of five mucosal transcripts in patients with Crohn's disease.
Eriksson A; Jennische E; Flach CF; Jorge A; Lange S
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):290-6. PubMed ID: 18334872
[TBL] [Abstract][Full Text] [Related]
15. Peroxisomes and peroxisomal enzymes in the human fetal small intestine.
Dauca M; Cable S; Calvert R; Colin S; Schilt J; Leheup B; Keller JM; Ménard D
Biol Neonate; 1996; 69(1):12-21. PubMed ID: 8777244
[TBL] [Abstract][Full Text] [Related]
16. Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis.
Vasquez N; Mangin I; Lepage P; Seksik P; Duong JP; Blum S; Schiffrin E; Suau A; Allez M; Vernier G; Tréton X; Doré J; Marteau P; Pochart P
Inflamm Bowel Dis; 2007 Jun; 13(6):684-92. PubMed ID: 17206669
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical localization of urate oxidase, fatty acyl-CoA oxidase, and catalase in bovine kidney peroxisomes.
Usuda N; Usman MI; Reddy MK; Hashimoto T; Reddy JK; Rao MS
J Histochem Cytochem; 1988 Mar; 36(3):253-8. PubMed ID: 3343509
[TBL] [Abstract][Full Text] [Related]
18. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
[TBL] [Abstract][Full Text] [Related]
19. Gene expression of group II phospholipase A2 in intestine in Crohn's disease.
Haapamäki MM; Grönroos JM; Nurmi H; Alanen K; Nevalainen TJ
Am J Gastroenterol; 1999 Mar; 94(3):713-20. PubMed ID: 10086656
[TBL] [Abstract][Full Text] [Related]
20. In situ heterogeneity of peroxisomal oxidase activities: an update.
Van den Munckhof RJ
Histochem J; 1996 Jun; 28(6):401-29. PubMed ID: 8863047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
